Pope Leo XIV made his first social media post on Tuesday in which he sent a message of peace, as he seeks to maintain an active social media presence through the official papal accounts. The ...

Willie was outside playing basketball, Soup was just starting Eikon Ministries. “If this man hadn’t saw the potential for me in my life enough to take me under his wing and to mentor disciple ...

With the recent release of patch 7.2, Final Fantasy XIV: Dawntrail has seen a good number of changes and additions. The one everyone has been waiting for is the new raid series, but there is still ...

SDVI, a platform provider for cloud-native media supply chains, has integrated its Rally media supply chain management platform with the new EIKON-iQ intelligent integration gateway to enable full ...

FFXIV patch 7.2 — the second major Dawntrail update — releases soon, alongside a lot of content which will be spread out through several micropatches. That said, there’ll still be stuff to ...

Biotechnology company Eikon Therapeutics announced the initial closing of a $350.7 million Series D financing round that it will use to advance its clinical-stage programs. The new funding brings ...

The upward trajectory continues for Eikon Therapeutics, which announced that it has raised $351 million to fund various cancer related clinical trials. The Series D funding unveiled Wednesday morning ...

US-based biotech Eikon Therapeutics has raised $350.7m in funding to advance its portfolio of cancer candidates. The company’s lead asset, EIK1001, is a systemically administered Toll-like ...

Eikon Therapeutics, a company headed by the former Merck executive who steered the cancer drug Keytruda to FDA approval, has raised $350.7 million to support a pipeline that includes a lead drug ...

Eikon Therapeutics is no stranger to eye-popping funding rounds, and the cancer-focused biotech has continued this trend with a $350.7 million series D to fuel its various clinical trials.

The funding, led by existing and new investors, is expected to support Eikon’s efforts to integrate advanced computing, automation, and data science that drives innovation in drug development. Eikon ...